Ovid Therapeutics Inc.
OVID US6904691010
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential in-class mechanism of action.
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Alexander Margaret A. PR |
0.56 USD |
5,279 Sold |
2,956 USD |
26/02/2025 | 26/02/2025 |
Rona Jeffrey A SR OFF |
0.56 USD |
3,902 Sold |
2,185 USD |
26/02/2025 | 26/02/2025 |
Alexander Margaret A. PR |
0.73 USD |
6,810 Bought |
4,971 USD |
27/01/2025 | 27/01/2025 |
Levin Jeremy M CEO |
2.76 USD |
18,248 Bought |
50,364 USD |
18/03/2024 | 18/03/2024 |